Syros Pharmaceuticals Inc. (SYRS) Declined -5.34% or -0.67 To Price $11.87 On Wednesday


Syros Pharmaceuticals Inc. (SYRS) declined -5.34% or -0.67 to $11.87. It is about 62512 shares traded, which is 70.58% compare to the average total volume 88569. The market cap of SYRS is $399.48 million. The year to date change is 20.31%. The 52 week price range is from $6.3 to $17.62. Price of SYRS have changed 1.79% during last week. It have changed 5.11% over last month, 15.26% over last 3 months, -1.42% over last 6 months and -14.29% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SYRS is 11.55. It is -2.70% below current price. The 200-day Moving Averages for SYRS is 11.51. It is -3.03% below current price. The 52-week High is 17.62. It is 48.44% from the current price. The 52-week Low is 6.3. It is -46.93% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of SYRS is 15.58 on 2018-08-31. Short % to float is 4.64%. There are some statistics of SYRS. It is has market cap $399.48 million. The share outstanding is 33.65 million. The average volume is 88569. It has 81.95M cash and 96000 in debt. The percent of top 15 Institution holding is 50.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SYRS is -57.11%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SYRS is -49.55%.


Tags:

Share this post